Key Highlights
- TuHURA Biosciences accessed a further $650,000 from its $50 million revolving Credit facility.
- The Facility is provided by Parkview Holdings.
- The draw secures Debt Capital for operational needs.
- The company continues to manage significant cash burn and a lack of Revenue alongside growing net losses.
TuHURA Biosciences, Inc. (NASDAQ: HURA) accessed a further $650,000 from its $50 million revolving credit facility provided by Parkview Holdings, securing debt capital for operational needs.
What Happened
The draw comes even as the company manages significant cash burn and a lack of revenue alongside growing net losses.
Market Reaction
The disclosed information does not include stock price or trading data for TuHURA Biosciences following the credit facility draw.
Outlook
Continued reliance on the $50 million Parkview Holdings revolving credit facility is likely to remain relevant for TuHURA Biosciences' operational funding needs, given the company's ongoing cash burn and lack of revenue.
FAQs
Q: How much did TuHURA Biosciences draw from its credit facility?
A: $650,000, from a $50 million revolving credit facility provided by Parkview Holdings.
Q: What is the purpose of this draw?
A: Securing debt capital for operational needs.
Q: What financial challenges does the company continue to face?
A: Significant cash burn, a lack of revenue, and growing net losses.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.